Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
Noosa News8 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News8 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
Noosa News13 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News15 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane